Protective Regulatory T Cell Generation in Autoimmune Diabetes by DNA Covaccination with Islet Antigens and a Selective CTLA-4 Ligand
Open Access
- 31 October 2006
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 14 (4) , 578-587
- https://doi.org/10.1016/j.ymthe.2006.03.021
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activityVaccine, 2005
- THE NOD MOUSE: A Model of Immune DysregulationAnnual Review of Immunology, 2005
- Frontline: Neuropilin‐1: a surface marker of regulatory T cellsEuropean Journal of Immunology, 2004
- TGF-β: the perpetrator of immune suppression by regulatory T cells and suicidal T cellsJournal of Leukocyte Biology, 2004
- Altering immune tolerance therapeutically: the power of negative thinkingJournal of Leukocyte Biology, 2003
- Endotoxin Contamination of Ovalbumin Suppresses Murine Immunologic Responses and Development of Airway Hyper-reactivityJournal of Biological Chemistry, 2003
- Induction of Autoimmune Diabetes Through Insulin (but Not GAD65) DNA Vaccination in Nonobese Diabetic and in RIP-B7.1 MiceDiabetes, 2002
- Vaccination with Glutamic Acid Decarboxylase Plasmid DNA Protects Mice from Spontaneous Autoimmune Diabetes and B7/CD28 Costimulation Circumvents That ProtectionClinical Immunology, 2001
- Identification of conserved amino acids in murine B7-1IgV domain critical for CTLA4\CD28:B7 interaction by site-directed mutagenesis: a novel structural model of the binding siteMolecular Immunology, 1998
- Mutational analysis and an alternatively spliced product of B7 defines its CD28/CTLA4-binding site on immunoglobulin C-like domain.The Journal of Experimental Medicine, 1995